new glp 1 drug GLP-1 drugs effective for type 1 diabetes in new study| STAT

Ny dansk studie om semaglutid (GLP 1 analog) mot alkoholberoende hos verviktiga: Semaglutide showed robust therapeutic effects in treatment seeking participants with obesity and alcohol use disorder and this trial supports previous preclinical and The use of GLP 1 receptor agonists was associated with a substantially lower long term risk for dry age related macular degeneration than the use of other weight loss medications in adults with overweight or obesity High throughput virtual screening to identify small molecule agonists for glucagon like peptide 1 receptor American Chemical Society The biggest and most comprehensive analysis of glucagon like peptide 1 (GLP 1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes. The findings were published